| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer EBioMedicine, 2018 | 206 | 2018 |
| Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways K Karagoz, R Sinha, KY Arga Omics: a journal of integrative biology 19 (2), 115-130, 2015 | 106 | 2015 |
| Tissue-specific molecular biomarker signatures of type 2 diabetes: an integrative analysis of transcriptomics and protein–protein interaction data B Calimlioglu, K Karagoz, T Sevimoglu, E Kilic, E Gov, KY Arga Omics: a journal of integrative biology 19 (9), 563-573, 2015 | 90 | 2015 |
| New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging HE Brighton, SP Angus, T Bo, J Roques, AC Tagliatela, DB Darr, ... Cancer research 78 (2), 542-557, 2018 | 75 | 2018 |
| A network-based cancer drug discovery: from integrated multi-omics approaches to precision medicine B Turanli, K Karagoz, G Gulfidan, R Sinha, A Mardinoglu, KY Arga Current pharmaceutical design 24 (32), 3778-3790, 2018 | 69 | 2018 |
| Multi-omic data interpretation to repurpose subtype specific drug candidates for breast cancer B Turanli, K Karagoz, G Bidkhori, R Sinha, ML Gatza, M Uhlen, ... Frontiers in genetics 10, 420, 2019 | 51 | 2019 |
| Proteomic and metabolic signatures of esophageal squamous cell carcinoma K Karagoz, H L Lehman, D B Stairs, R Sinha, K Y Arga Current cancer drug targets 16 (8), 721-736, 2016 | 44 | 2016 |
| Integration of multiple biological features yields high confidence human protein interactome K Karagoz, T Sevimoglu, KY Arga Journal of theoretical biology 403, 85-96, 2016 | 36 | 2016 |
| The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers Molecular Therapy-Nucleic Acids, 2018 | 32* | 2018 |
| Improving accuracy of GPT-3/4 results on biomedical data using a retrieval-augmented language model D Soong, S Sridhar, H Si, JS Wagner, ACC Sá, CY Yu, K Karagoz, ... PLOS Digital Health 3 (8), e0000568, 2024 | 29 | 2024 |
| “Omics” of selenium biology: a prospective study of plasma proteome network before and after selenized-yeast supplementation in healthy men I Sinha, K Karagoz, RL Fogle, CS Hollenbeak, AH Zea, KY Arga, ... Omics: a journal of integrative biology 20 (4), 202-213, 2016 | 28 | 2016 |
| Differentiation among prostate cancer patients with Gleason score of 7 using histopathology whole-slide image and genomic data J Ren, K Karagoz, M Gatza, DJ Foran, X Qi Proceedings of Spie--the International Society for Optical Engineering 10579 …, 2018 | 27 | 2018 |
| Recurrence analysis on prostate cancer patients with Gleason score 7 using integrated histopathology whole-slide images and genomic data through deep neural networks J Ren, K Karagoz, ML Gatza, EA Singer, E Sadimin, DJ Foran, X Qi Journal of Medical Imaging 5 (4), 047501-047501, 2018 | 23 | 2018 |
| Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis K Karagoz, GA Mehta, CA Khella, P Khanna, ML Gatza EBioMedicine 50, 191-202, 2019 | 22 | 2019 |
| Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma S Gooding, N Ansari-Pour, M Kazeroun, K Karagoz, A Polonskaia, ... Blood, The Journal of the American Society of Hematology 140 (16), 1816-1821, 2022 | 19 | 2022 |
| Assessment of high-confidence protein–protein interactome in yeast K Karagoz, KY Arga Computational Biology and Chemistry 45, 1-8, 2013 | 17 | 2013 |
| Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma K Kurata, A James-Bott, MA Tye, L Yamamoto, MK Samur, YT Tai, ... Blood cancer journal 13 (1), 12, 2023 | 12 | 2023 |
| Aggressive mammary cancers lacking lymphocytic infiltration arise in irradiated mice and can be prevented by dietary intervention C Omene, L Ma, J Moore, H Ouyang, I Illa-Bochaca, W Chou, MS Patel, ... Cancer immunology research 8 (2), 217-229, 2020 | 10 | 2020 |
| Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’[EBioMedicine 38 (2018) 100–112] P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 52, 2020 | 7 | 2020 |
| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBiomedicine 38: 100–112 P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... | 7 | 2018 |
Kazim Yalcin ArgaProfessor of Bioengineering @ Marmara Universityایمیل تأیید شده در marmara.edu.tr